2Tepper D. Effect of metoprolol CR/XL in chronic heart failure: Meto- prolol CR/XL Randomised intervention Trial in Congestive heart fail- ure ( MERIT - HF). Lancet, 1999,353:2001 -2007.
3Kulbertus H. The cardiac insufficiency bisoprolol study Ⅱ ( CIBIS -Ⅱ ) : a randomised trial. Lancet, 1999,353:9 - 13.
4Packer M, Coats A J, Fowler MB, et al. Beneficial effects of meto- prolol in idiopathic dilated cardiomyopathy. Metoprolol in Dilated Cardiomyopathy (MDC) Trial Study Group. lancet, 1993, 11: 1441 - 1446.
5Dahlof B, Lindholm LH, Hansson L, et al. Morbidity and mortality in the Swedish trail in 01d patients with Hypertension ( STOP - Hy-pertension). Lancet, 1991,338:1281 - 1285.
6Hansson L, Lindholm LH, Ekbom T, et al. Randomised trial of old and new antihypertensive drugs in elderly patients: cardiovasculaer mortality and morbidity the Swedish trial in old patients with Hyper- tension - 2 study. Lancet, 1999,354 : 1751 - 1756.
7Hansson L, Lindholm LH, Niskanen L, et al. Effect of angiotensin - converting - enzyme inhibiton compared with conventional therapy on cardiovascular morbidity and mortality in hypertension. Lancet, 1999,353:611 - 616.
8Held C, Hjemdahl P, Rehnqvist N, et al. Fibrinolytic variables and cardiovascular prognosis in patients with stable angina pectoris treated with verapamil or metoprolol. Results from the angina prognosis study in Stockholm. Circulation, 1997,95:2380 - 2386.
9Dargie HJ, Ford I, Fox KM. Total ischaemic burden European trial (TIBET). Effects of ischaemia and treatment with atenolol, nifedip-ine SR and their combination on outcome in patients with chronic sta- ble angina. The TIBET study group. Eur Heart J, 1996, 17: 104 -112.
10Pepine C J, Cohn PF, Deedwania PC,et al. Effects of treatment on outcome in mildly symptomatic patients with ischemia during daily life. The Atenolol silent ischemia study (ASIST). Circulation, 1994,90:762 - 768.
